Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Letter: Congress of Neurological Surgeons Female International Think Tank Report: Much Progress, Still Work to Be Done.

Sweet JA, Holanda VM, Rao G, Kalkanis SN, Sharan AD, Benzil DL.

Neurosurgery. 2019 Sep 1;85(3):E599-E606. doi: 10.1093/neuros/nyz254. No abstract available.

PMID:
31418029
2.

Sarcopenia Predicts Overall Survival in Patients with Lung, Breast, Prostate, or Myeloma Spine Metastases Undergoing Stereotactic Body Radiation Therapy (SBRT), Independent of Histology.

Zakaria HM, Llaniguez JT, Telemi E, Chuang M, Abouelleil M, Wilkinson B, Chandra A, Boyce-Fappiano D, Elibe E, Schultz L, Siddiqui F, Griffith B, Kalkanis SN, Lee IY, Chang V.

Neurosurgery. 2019 Jun 24. pii: nyz216. doi: 10.1093/neuros/nyz216. [Epub ahead of print]

PMID:
31232439
3.

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Surgery in the Management of Adults With Metastatic Brain Tumors.

Nahed BV, Alvarez-Breckenridge C, Brastianos PK, Shih H, Sloan A, Ammirati M, Kuo JS, Ryken TC, Kalkanis SN, Olson JJ.

Neurosurgery. 2019 Mar 1;84(3):E152-E155. doi: 10.1093/neuros/nyy542.

PMID:
30629227
4.
5.

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Whole Brain Radiation Therapy in Adults With Newly Diagnosed Metastatic Brain Tumors.

Gaspar LE, Prabhu RS, Hdeib A, McCracken DJ, Lasker GF, McDermott MW, Kalkanis SN, Olson JJ.

Neurosurgery. 2019 Mar 1;84(3):E159-E162. doi: 10.1093/neuros/nyy541.

PMID:
30629211
6.

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Steroids in the Treatment of Adults With Metastatic Brain Tumors.

Ryken TC, Kuo JS, Prabhu RS, Sherman JH, Kalkanis SN, Olson JJ.

Neurosurgery. 2019 Mar 1;84(3):E189-E191. doi: 10.1093/neuros/nyy546.

PMID:
30629207
7.

The impact of 5-aminolevulinic acid on extent of resection in newly diagnosed high grade gliomas: a systematic review and single institutional experience.

Haider SA, Lim S, Kalkanis SN, Lee IY.

J Neurooncol. 2019 Feb;141(3):507-515. doi: 10.1007/s11060-018-03061-3. Epub 2018 Dec 1.

PMID:
30506501
8.

Durable complete responses in some recurrent high-grade glioma patients treated with Toca 511 + Toca FC.

Cloughesy TF, Landolfi J, Vogelbaum MA, Ostertag D, Elder JB, Bloomfield S, Carter B, Chen CC, Kalkanis SN, Kesari S, Lai A, Lee IY, Liau LM, Mikkelsen T, Nghiemphu P, Piccioni D, Accomando W, Diago OR, Hogan DJ, Gammon D, Kasahara N, Kheoh T, Jolly DJ, Gruber HE, Das A, Walbert T.

Neuro Oncol. 2018 Sep 3;20(10):1383-1392. doi: 10.1093/neuonc/noy075.

PMID:
29762717
9.

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Treatment of Adults With Vestibular Schwannomas: Executive Summary.

Olson JJ, Kalkanis SN, Ryken TC.

Neurosurgery. 2018 Feb 1;82(2):129-134. doi: 10.1093/neuros/nyx586.

PMID:
29309649
10.

Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group.

Alexander BM, Brown PD, Ahluwalia MS, Aoyama H, Baumert BG, Chang SM, Gaspar LE, Kalkanis SN, Macdonald DR, Mehta MP, Soffietti R, Suh JH, van den Bent MJ, Vogelbaum MA, Wefel JS, Lee EQ, Wen PY; Response Assessment in Neuro-Oncology (RANO) group.

Lancet Oncol. 2018 Jan;19(1):e33-e42. doi: 10.1016/S1470-2045(17)30692-7. Review.

PMID:
29304360
11.

Rationale and design of the 500-patient, 3-year, and prospective Vigilant ObservatIon of GlIadeL WAfer ImplaNT registry.

Lillehei KO, Kalkanis SN, Liau LM, Mydland DE, Olson J, Paleologos NA, Ryken T, Johnson T, Scullin E.

CNS Oncol. 2018 Apr;7(2):CNS08. doi: 10.2217/cns-2017-0036. Epub 2017 Dec 5.

12.

Glioma CpG island methylator phenotype (G-CIMP): biological and clinical implications.

Malta TM, de Souza CF, Sabedot TS, Silva TC, Mosella MS, Kalkanis SN, Snyder J, Castro AVB, Noushmehr H.

Neuro Oncol. 2018 Apr 9;20(5):608-620. doi: 10.1093/neuonc/nox183. Review.

13.

Intraoperative Raman Spectroscopy.

Brusatori M, Auner G, Noh T, Scarpace L, Broadbent B, Kalkanis SN.

Neurosurg Clin N Am. 2017 Oct;28(4):633-652. doi: 10.1016/j.nec.2017.05.014. Epub 2017 Aug 10. Review.

PMID:
28917291
14.

Reoperation for Recurrent Glioblastoma Multiforme.

Robin AM, Lee I, Kalkanis SN.

Neurosurg Clin N Am. 2017 Jul;28(3):407-428. doi: 10.1016/j.nec.2017.02.007. Review.

PMID:
28600015
15.

Shining light on neurosurgery diagnostics using Raman spectroscopy.

Broadbent B, Tseng J, Kast R, Noh T, Brusatori M, Kalkanis SN, Auner GW.

J Neurooncol. 2016 Oct;130(1):1-9. Epub 2016 Aug 13. Review.

PMID:
27522510
16.

Serum proteins are extracted along with monolayer cells in plasticware and interfere with protein analysis.

Hong X, Meng Y, Kalkanis SN.

J Biol Methods. 2016;3(4). pii: e51. Epub 2016 Aug 13.

17.

Prophylactic antiepileptic drug administration following brain tumor resection: results of a recent AANS/CNS Section on Tumors survey.

Dewan MC, Thompson RC, Kalkanis SN, Barker FG 2nd, Hadjipanayis CG.

J Neurosurg. 2017 Jun;126(6):1772-1778. doi: 10.3171/2016.4.JNS16245. Epub 2016 Jun 24.

PMID:
27341048
18.

Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma.

Cloughesy TF, Landolfi J, Hogan DJ, Bloomfield S, Carter B, Chen CC, Elder JB, Kalkanis SN, Kesari S, Lai A, Lee IY, Liau LM, Mikkelsen T, Nghiemphu PL, Piccioni D, Walbert T, Chu A, Das A, Diago OR, Gammon D, Gruber HE, Hanna M, Jolly DJ, Kasahara N, McCarthy D, Mitchell L, Ostertag D, Robbins JM, Rodriguez-Aguirre M, Vogelbaum MA.

Sci Transl Med. 2016 Jun 1;8(341):341ra75. doi: 10.1126/scitranslmed.aad9784.

PMID:
27252174
19.

The role of radiotherapy in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.

Ryken TC, Parney I, Buatti J, Kalkanis SN, Olson JJ.

J Neurooncol. 2015 Dec;125(3):551-83. doi: 10.1007/s11060-015-1948-1. Epub 2015 Nov 3. Review.

PMID:
26530266
20.

The role of surgery in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.

Aghi MK, Nahed BV, Sloan AE, Ryken TC, Kalkanis SN, Olson JJ.

J Neurooncol. 2015 Dec;125(3):503-30. doi: 10.1007/s11060-015-1867-1. Epub 2015 Nov 3. Review.

PMID:
26530265
21.

Management of patients with recurrence of diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.

Nahed BV, Redjal N, Brat DJ, Chi AS, Oh K, Batchelor TT, Ryken TC, Kalkanis SN, Olson JJ.

J Neurooncol. 2015 Dec;125(3):609-30. doi: 10.1007/s11060-015-1910-2. Epub 2015 Nov 3. Review.

PMID:
26530264
22.

The role of neuropathology in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.

Cahill DP, Sloan AE, Nahed BV, Aldape KD, Louis DN, Ryken TC, Kalkanis SN, Olson JJ.

J Neurooncol. 2015 Dec;125(3):531-49. doi: 10.1007/s11060-015-1909-8. Epub 2015 Nov 3. Review.

PMID:
26530263
23.

The role of imaging in the management of adults with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.

Fouke SJ, Benzinger T, Gibson D, Ryken TC, Kalkanis SN, Olson JJ.

J Neurooncol. 2015 Dec;125(3):457-79. doi: 10.1007/s11060-015-1908-9. Epub 2015 Nov 3. Review.

PMID:
26530262
24.

The role of initial chemotherapy for the treatment of adults with diffuse low grade glioma : A systematic review and evidence-based clinical practice guideline.

Ziu M, Kalkanis SN, Gilbert M, Ryken TC, Olson JJ.

J Neurooncol. 2015 Dec;125(3):585-607. doi: 10.1007/s11060-015-1931-x. Epub 2015 Nov 3. Review.

PMID:
26530261
25.

The role of emerging therapy in the management of patients with diffuse low grade glioma.

Sloan AE, Okada H, Ryken TC, Kalkanis SN, Olson JJ.

J Neurooncol. 2015 Dec;125(3):631-5. doi: 10.1007/s11060-015-1865-3. Epub 2015 Nov 3. Review.

PMID:
26530260
26.

The role of biopsy in the management of patients with presumed diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.

Ragel BT, Ryken TC, Kalkanis SN, Ziu M, Cahill D, Olson JJ.

J Neurooncol. 2015 Dec;125(3):481-501. doi: 10.1007/s11060-015-1866-2. Epub 2015 Nov 3. Review.

PMID:
26530259
27.

Identification of regions of normal grey matter and white matter from pathologic glioblastoma and necrosis in frozen sections using Raman imaging.

Kast R, Auner G, Yurgelevic S, Broadbent B, Raghunathan A, Poisson LM, Mikkelsen T, Rosenblum ML, Kalkanis SN.

J Neurooncol. 2015 Nov;125(2):287-95. doi: 10.1007/s11060-015-1929-4. Epub 2015 Sep 10.

PMID:
26359131
28.

Evidence-based clinical practice parameter guidelines for the treatment of adults with diffuse low grade glioma: introduction and methods.

Olson JJ, Kalkanis SN, Ryken TC.

J Neurooncol. 2015 Dec;125(3):449-56. doi: 10.1007/s11060-015-1847-5. Epub 2015 Jun 25. No abstract available.

PMID:
26108657
29.

Response assessment criteria for brain metastases: proposal from the RANO group.

Lin NU, Lee EQ, Aoyama H, Barani IJ, Barboriak DP, Baumert BG, Bendszus M, Brown PD, Camidge DR, Chang SM, Dancey J, de Vries EG, Gaspar LE, Harris GJ, Hodi FS, Kalkanis SN, Linskey ME, Macdonald DR, Margolin K, Mehta MP, Schiff D, Soffietti R, Suh JH, van den Bent MJ, Vogelbaum MA, Wen PY; Response Assessment in Neuro-Oncology (RANO) group.

Lancet Oncol. 2015 Jun;16(6):e270-8. doi: 10.1016/S1470-2045(15)70057-4. Epub 2015 May 27. Review.

PMID:
26065612
30.

Setting the stage: local delivery of cytoreductive agents for the treatment of glioblastoma.

Kalkanis SN.

Neuro Oncol. 2015 Mar;17 Suppl 2:ii1-ii2. doi: 10.1093/neuonc/nov001. No abstract available.

31.

Clinical practice guidelines in the AANS/CNS Section on Tumors: past, present and future directions.

Linskey ME, Olson JJ, Mitchell LS, Kalkanis SN.

J Neurooncol. 2014 Sep;119(3):557-68. doi: 10.1007/s11060-014-1497-z. Epub 2014 Aug 1. No abstract available.

PMID:
25081972
32.

Raman molecular imaging of brain frozen tissue sections.

Kast RE, Auner GW, Rosenblum ML, Mikkelsen T, Yurgelevic SM, Raghunathan A, Poisson LM, Kalkanis SN.

J Neurooncol. 2014 Oct;120(1):55-62. doi: 10.1007/s11060-014-1536-9. Epub 2014 Jul 20.

PMID:
25038847
33.

Through the patient's eyes: the value of a comprehensive brain tumor center.

Robin AM, Walbert T, Mikkelsen T, Kalkanis SN, Rock J, Lee I, Rosenblum ML.

J Neurooncol. 2014 Sep;119(3):465-72. doi: 10.1007/s11060-014-1494-2. Epub 2014 Jul 16. Review.

PMID:
25026994
34.

Through the patient's eyes: an emphasis on patient-centered values in operative decision making in the management of malignant glioma.

Robin AM, Kalkanis SN, Rock J, Lee I, Rosenblum ML.

J Neurooncol. 2014 Sep;119(3):473-9. doi: 10.1007/s11060-014-1492-4. Epub 2014 Jun 25. Review.

PMID:
24962199
35.

The role of cytoreductive surgery in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.

Ryken TC, Kalkanis SN, Buatti JM, Olson JJ; AANS/CNS Joint Guidelines Committee.

J Neurooncol. 2014 Jul;118(3):479-88. doi: 10.1007/s11060-013-1336-7. Epub 2014 Apr 23. Review.

PMID:
24756348
36.

The role of targeted therapies in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.

Olson JJ, Nayak L, Ormond DR, Wen PY, Kalkanis SN, Ryken TC; AANS/CNS Joint Guidelines Committee.

J Neurooncol. 2014 Jul;118(3):557-99. doi: 10.1007/s11060-013-1339-4. Epub 2014 Apr 17. Review.

PMID:
24740195
37.

The role of cytotoxic chemotherapy in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.

Olson JJ, Nayak L, Ormond DR, Wen PY, Kalkanis SN; AANS/CNS Joint Guidelines Committee.

J Neurooncol. 2014 Jul;118(3):501-55. doi: 10.1007/s11060-013-1338-5. Epub 2014 Apr 17. Review.

PMID:
24740194
38.

The role of neuropathology in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.

Brat DJ, Ryken TC, Kalkanis SN, Olson JJ; AANS/CNS Joint Guidelines Committee.

J Neurooncol. 2014 Jul;118(3):461-78. doi: 10.1007/s11060-013-1331-z. Epub 2014 Apr 15. Review.

PMID:
24733643
39.

The role of radiotherapy in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.

Ryu S, Buatti JM, Morris A, Kalkanis SN, Ryken TC, Olson JJ; AANS/CNS Joint Guidelines Committee.

J Neurooncol. 2014 Jul;118(3):489-99. doi: 10.1007/s11060-013-1337-6. Epub 2014 Apr 12. Review.

PMID:
24728785
40.

The role of imaging in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.

Ryken TC, Aygun N, Morris J, Schweizer M, Nair R, Spracklen C, Kalkanis SN, Olson JJ; AANS/CNS Joint Guidelines Committee.

J Neurooncol. 2014 Jul;118(3):435-60. doi: 10.1007/s11060-013-1330-0. Epub 2014 Apr 9. Review.

PMID:
24715656
41.

Introduction, rationale, and methodology.

Olson JJ, Ryken TC, Kalkanis SN; AANS/CNS Joint Guidelines Committee.

J Neurooncol. 2014 Jul;118(3):429-34. doi: 10.1007/s11060-013-1329-6. Epub 2014 Apr 9. No abstract available.

PMID:
24715655
42.

It is time to reevaluate the management of patients with brain metastases.

Kondziolka D, Kalkanis SN, Mehta MP, Ahluwalia M, Loeffler JS.

Neurosurgery. 2014 Jul;75(1):1-9. doi: 10.1227/NEU.0000000000000354.

PMID:
24662510
43.

Current approaches to the treatment of metastatic brain tumours.

Owonikoko TK, Arbiser J, Zelnak A, Shu HK, Shim H, Robin AM, Kalkanis SN, Whitsett TG, Salhia B, Tran NL, Ryken T, Moore MK, Egan KM, Olson JJ.

Nat Rev Clin Oncol. 2014 Apr;11(4):203-22. doi: 10.1038/nrclinonc.2014.25. Epub 2014 Feb 25. Review.

44.

Raman spectroscopy to distinguish grey matter, necrosis, and glioblastoma multiforme in frozen tissue sections.

Kalkanis SN, Kast RE, Rosenblum ML, Mikkelsen T, Yurgelevic SM, Nelson KM, Raghunathan A, Poisson LM, Auner GW.

J Neurooncol. 2014 Feb;116(3):477-85. doi: 10.1007/s11060-013-1326-9. Epub 2014 Jan 4.

PMID:
24390405
45.

Patterns of failure after radiosurgery to two different target volumes of enhancing lesions with and without FLAIR abnormalities in recurrent glioblastoma multiforme.

Kim EY, Yechieli R, Kim JK, Mikkelsen T, Kalkanis SN, Rock J, Rosenblum M, Ryu S.

J Neurooncol. 2014 Jan;116(2):291-7. doi: 10.1007/s11060-013-1290-4. Epub 2013 Oct 31.

PMID:
24173682
46.

Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group.

Lin NU, Wefel JS, Lee EQ, Schiff D, van den Bent MJ, Soffietti R, Suh JH, Vogelbaum MA, Mehta MP, Dancey J, Linskey ME, Camidge DR, Aoyama H, Brown PD, Chang SM, Kalkanis SN, Barani IJ, Baumert BG, Gaspar LE, Hodi FS, Macdonald DR, Wen PY; Response Assessment in Neuro-Oncology (RANO) group.

Lancet Oncol. 2013 Sep;14(10):e407-16. doi: 10.1016/S1470-2045(13)70308-5. Review.

PMID:
23993385
47.

Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group.

Lin NU, Lee EQ, Aoyama H, Barani IJ, Baumert BG, Brown PD, Camidge DR, Chang SM, Dancey J, Gaspar LE, Harris GJ, Hodi FS, Kalkanis SN, Lamborn KR, Linskey ME, Macdonald DR, Margolin K, Mehta MP, Schiff D, Soffietti R, Suh JH, van den Bent MJ, Vogelbaum MA, Wefel JS, Wen PY; Response Assessment in Neuro-Oncology (RANO) group.

Lancet Oncol. 2013 Sep;14(10):e396-406. doi: 10.1016/S1470-2045(13)70311-5. Review.

PMID:
23993384
48.

Neuro-oncologic applications of exosomes, microvesicles, and other nano-sized extracellular particles.

Gonda DD, Akers JC, Kim R, Kalkanis SN, Hochberg FH, Chen CC, Carter BS.

Neurosurgery. 2013 Apr;72(4):501-10. doi: 10.1227/NEU.0b013e3182846e63. Review.

PMID:
23277376
49.

Multimodal actions of neural stem cells in a mouse model of ALS: a meta-analysis.

Teng YD, Benn SC, Kalkanis SN, Shefner JM, Onario RC, Cheng B, Lachyankar MB, Marconi M, Li J, Yu D, Han I, Maragakis NJ, Lládo J, Erkmen K, Redmond DE Jr, Sidman RL, Przedborski S, Rothstein JD, Brown RH Jr, Snyder EY.

Sci Transl Med. 2012 Dec 19;4(165):165ra164. doi: 10.1126/scitranslmed.3004579.

PMID:
23253611
50.

Glioblastoma cell line-derived spheres in serum‑containing medium versus serum-free medium: a comparison of cancer stem cell properties.

Hong X, Chedid K, Kalkanis SN.

Int J Oncol. 2012 Nov;41(5):1693-700. doi: 10.3892/ijo.2012.1592. Epub 2012 Aug 21.

PMID:
22922964

Supplemental Content

Loading ...
Support Center